BRONCHEX COUGH SYRUP 93.67 MG / 5 ML
GLYCERINE : 93.67 MG / 5 ML OIL OF FIR : 2.28 MG / 5 ML AMMONIUM CARBONATE : 18.28 MG / 5 ML AMMONIUM CHLORIDE : 205.62 MG / 5 ML AMMONIA : 2.699 MG / 5 ML WHITE PINE : 913.87 MG / 5 ML GLYCYRRHIZA GLABRA : 68.54 MG / 5 ML MENTHOL : 4.57 MG / 5 ML · DIN 00756865 · HILARY'S DISTIBUTION LTD.
Health Canada status: CANCELLED POST MARKET
What is BRONCHEX COUGH SYRUP?
BRONCHEX COUGH SYRUP 93.67 MG / 5 ML contains GLYCERINE : 93.67 MG / 5 ML OIL OF FIR : 2.28 MG / 5 ML AMMONIUM CARBONATE : 18.28 MG / 5 ML AMMONIUM CHLORIDE : 205.62 MG / 5 ML AMMONIA : 2.699 MG / 5 ML WHITE PINE : 913.87 MG / 5 ML GLYCYRRHIZA GLABRA : 68.54 MG / 5 ML MENTHOL : 4.57 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 00756865, held by HILARY'S DISTIBUTION LTD., supplied as SYRUP for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 24-Jul-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00756865 |
|---|---|
| Brand name | BRONCHEX COUGH SYRUP |
| Generic / active ingredient | GLYCERINE : 93.67 MG / 5 ML OIL OF FIR : 2.28 MG / 5 ML AMMONIUM CARBONATE : 18.28 MG / 5 ML AMMONIUM CHLORIDE : 205.62 MG / 5 ML AMMONIA : 2.699 MG / 5 ML WHITE PINE : 913.87 MG / 5 ML GLYCYRRHIZA GLABRA : 68.54 MG / 5 ML MENTHOL : 4.57 MG / 5 ML |
| Manufacturer | HILARY'S DISTIBUTION LTD. |
| Strength | 93.67 MG / 5 ML |
| Dosage form | SYRUP |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R05CA10 COMBINATIONS |
| AHFS class | 48:16.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 24-Jul-2001 |
| Original market date | 1988-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R05CA10 COMBINATIONS. 4 of 42 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CREO-RECTAL ADULTES/ADULTS | 1.5 MG | SUPPOSITORY | LABORATOIRES CONFAB INC | MARKETED | DIN 00299561 |
| CREO-RECTAL ENFANTS/CHILDREN | 200 MG | SUPPOSITORY | LABORATOIRES CONFAB INC | MARKETED | DIN 00299596 |
| DEMO-CINEOL ADULTES/ADULTS | 200 MG | SUPPOSITORY | LABORATOIRES CONFAB INC | MARKETED | DIN 00319716 |
| DEMO-CINEOL ENFANTS/CHILDREN | 185 MG | SUPPOSITORY | LABORATOIRES CONFAB INC | MARKETED | DIN 00319724 |
| ALSIDRINE LIQ | 7 MG | LIQUID | ALSI CIE LTEE | CANCELLED POST MARKET | DIN 00429058 |
| BABYS OWN COUGH SYR | 1 G / 100 ML | LIQUID | G.T. FULFORD PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00395390 |
| BISMUTAL ADULTS | 150 MG | SUPPOSITORY | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | DIN 00535168 |
| BRONCH EZE | 4 MG / 5 ML | SYRUP | PHARMAVITE LABORATORIES (1987) INC. | CANCELLED POST MARKET | DIN 00484709 |
| BRONCHIAL COUGH SYR | 45 MG | SYRUP | THERALAB INC. | CANCELLED POST MARKET | DIN 00525499 |
| BRONCHO TUSS ADULT | 60 MG | SUPPOSITORY | PRODUITS FRANCAIS LABS INC. | CANCELLED POST MARKET | DIN 00540897 |
Who else supplies COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COMBINATIONS appears in 5 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.